HRS9531 injection for obesity with sleep apnea
Treatments studied
Part of Hormones & metabolism, Lungs & breathing clinical trials.
This study tests an injectable medication called HRS9531 for people with obesity and obstructive sleep apnea. The goal is to see if it can help reduce breathing pauses during sleep and promote weight loss.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 65 years old.
- Your body mass index (BMI) is between 24 and 42.
- You have been diagnosed with obstructive sleep apnea (at least 15 breathing pauses per hour during sleep).
- You have been trying to control your weight with diet and exercise for at least 3 months, and your weight has not changed by more than 5 kg (11 lbs) in the last 3 months.
- You do not have diabetes, certain thyroid or hormone conditions, or a history of some cancers or mental health conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an injection called HRS9531 to see if it helps people with obstructive sleep apnea (OSA) and obesity who already use a CPAP or similar breathing device. It may help by reducing weight and improving breathing during sleep.
This trial tests an injectable medication (HRS9531) to see if it helps people with both obstructive sleep apnea and obesity. It compares the drug to a placebo (no active medicine) to check safety and effectiveness.
This study tests an injected medication to see if it helps reduce the severity of obstructive sleep apnea in people with obesity. The trial will compare the drug to a placebo over several months to check safety and effectiveness.
This study tests whether a new injectable medicine called NNC0487-0111 helps people with excess weight and moderate-to-severe obstructive sleep apnea (a condition where breathing stops repeatedly during sleep) lose weight and improve their sleep apnea—without needing a CPAP machine. The goal is to see if better weight loss can reduce sleep apnea symptoms.
This study tests a new injectable medicine (NNC0487-0111) to help people lose weight and improve obstructive sleep apnea (a breathing condition during sleep). You must already be using a CPAP machine (positive airway pressure device) for your sleep apnea.
This study tests an injection for people with obstructive sleep apnea who cannot or will not use a CPAP machine. The treatment may help reduce sleep apnea severity and aid in weight loss.
Hear when a new Weight Management trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.